Clinical trial Recruiting at 1 site Interventional Ages 21 to 80

Embolization treatment for chronic shoulder pain

Official title: Efficacy of Lipiodol Embolization for Chronic Tendinopathy of the Rotator Cuff

Run by Brigham and Women's Hospital · NCT06095050 · Data updated 2026-11-12

This study is testing if adding a special procedure called embolization to physical therapy can help people with ongoing shoulder pain from rotator cuff issues feel better compared to just doing physical therapy alone.

Quick facts

Study typeInterventional
Ages21 Years to 80 Years
SexAll
Enrollment41 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJanuary 16, 2025
Main results expectedJanuary 16, 2027
Study endsApril 21, 2028
Registry record updatedFebruary 6, 2026
Trial IDNCT06095050 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with moderate to severe shoulder pain refractory to at least 6 months of conservative treatment.

Probably not a fit

Patients with complete full thickness tendon tears or significant peripheral arterial disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of transcatheter arterial embolization (TAE) combined with physical therapy (PT) compared to PT alone in patients suffering from moderate to severe shoulder pain due to rotator cuff tendinopathy that has not improved with conservative treatments. Participants will undergo a shoulder MRI to confirm tendinopathy and will be randomized into two groups: one receiving TAE followed by structured PT, and the other receiving only structured PT. The primary outcome is the change in shoulder pain after 12 months, along with assessments of safety and various patient-reported outcomes.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce shoulder pain and improve function for patients with chronic refractory tendinopathy.

How similar studies have gone: While embolization for shoulder pain is a novel approach, similar studies in other areas have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male, female, transgender female, transgender male, non-binary
2. Moderate to severe shoulder pain (VAS \> 40)
3. Pain refractory to at least 6 months of physician-directed conservative therapy (analgesics or injections or PT), including a minimum of 6 weeks of PT
4. Willing, able, and mentally competent to provide informed consent and to tolerate angiography and physical therapy

Exclusion Criteria:

1. History of peripheral arterial disease or peripheral artery disease symptoms including claudication, diminished or absent upper/lower extremity pulses, or known upper extremity arterial atherosclerosis or occlusion that would limit selective angiography
2. Known history of anaphylaxis to iodinated contrast agents or gadolinium based contrast
3. Acute kidney injury
4. Allergy to poppy seeds or lipiodol
5. Renal dysfunction as defined by serum creatinine \>1.6 dl/mg or eGFR \<60 obtained within 30 days of procedure.
6. Uncorrectable coagulopathy (platelet count \< 50,000, international normalized ratio \>1.8 within 30 days of procedure
7. Active systemic or local upper extremity infection
8. Patient pregnant, intending to become pregnant during the study.
9. Prior shoulder replacement surgery
10. Prior rotator cuff repair surgery
11. Previous history of complete full-thickness tear of the rotator cuff
12. Presence of non-MRI compatible devices (e.g., non-compatible cardiac pacemaker).

Where it's running

  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.